Melanie Butler-Gauthier

Melanie Butler-Gauthier has experience in various roles within the pharmaceutical and biotechnology industry, including as a Principal Toxicology Associate at CRISPR Therapeutics. Prior to this, Melanie also worked at Consultations SBG Inc. and Sangamo Therapeutics, Inc. Melanie's expertise includes authoring nonclinical IND sections, managing POC/preliminary safety studies, and providing integrative toxicological evaluations. Additionally, Melanie has experience in nonclinical project management and data analysis. Melanie has also contributed to research and teaching at California Polytechnic State University-San Luis Obispo.